Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
Enrolling by invitationNCT06808321
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Turkey.
Study details
- Official title
- Evaluation of Clinical Outcomes of Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients in the Turkish Population
- Conditions
- Chronic Coronary Syndrome
- Hypertension
- Angina Pectoris
- Interventions
- Drug: Benidipine Hydrochloride
- Sponsor
- The Society of Prevention and Awareness of Cardiovascular Diseases
- Start date
- 2025-03-01
- Primary completion
- 2026-01-01
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment * Male or female outpatients, 18-80 years of age * Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month * Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month * Those who signed the written informed consent form Exclusion Criteria: * Patients with secondary hypertension * Emergency hypertensive patients * Having to take other medications during the study that may affect blood pressure * Allergic to DHP calcium antagonists * Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia * Severe renal or hepatic dysfunction * Pregnant or lactating women * Participation in other clinical trials within 3 months prior to this study * Patients who did not sign the consent form of the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06808321